They've identified which grants wouldn't have been funded had similar cuts been made earlier in this century and tracked the ...

The companion diagnostic was once a niche sidekick in oncology, a modest tool for identifying the right patients for a small ...

The FDA agrees that the Company may follow 505(b)(2) regulatory pathway to non-invasively treat basal cell carcinoma (BCC) of ...

In 2022, the US National Institutes of Health (NIH) awarded Chanda an Antiviral Drug Discovery (AViDD) grant that provided ...

Analysts are already warning that U.S. consumers could see higher prices due to new tariffs President Donald Trump plans to ...

The NHS must pay more towards new drug development to help cut prices for Americans, a major US pharmaceutical giant has said ...

Noxopharm Ltd. ( ($AU:NOX) ) has issued an announcement. Noxopharm Limited has made significant strides in its drug development efforts, ...

Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...

Proposed NIH funding cuts are a pressing concern when one considers the broader impacts of reduced research funding.

Gleevec, a cancer drug first approved for sale in 2001, has dramatically changed the lives of people with chronic myeloid ...

The number of therapies developed in China has doubled in recent years, and approximately one-third of the global licensing ...

Earlier this year, two new drugs that have been shown in global trials to slow early-stage Alzheimer's disease, donanemab and ...